Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Special cells can help regrow hair in alopecia areata.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

A woman's hair loss looked like a different condition due to her hairstyle, and treatment stopped further hair loss but didn't regrow hair.

Toluidine blue helps accurately diagnose and treat certain skin tumors in surgery.

PRP or nanofat injections improve scar tissue quality but don't significantly boost hair transplant results for scarring hair loss.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Stress may trigger hair loss by affecting immune protection in hair follicles.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.